76 related articles for article (PubMed ID: 11448224)
1. Nonpeptidic, monocharged, cell permeable ligands for the p56lck SH2 domain.
Proudfoot JR; Betageri R; Cardozo M; Gilmore TA; Glynn S; Hickey ER; Jakes S; Kabcenell A; Kirrane TM; Tibolla AK; Lukas S; Patel UR; Sharma R; Yazdanian M; Moss N; Beaulieu PL; Cameron DR; Ferland JM; Gauthier J; Gillard J; Gorys V; Poirier M; Rancourt J; Wernic D; Llinas-Brunet M
J Med Chem; 2001 Jul; 44(15):2421-31. PubMed ID: 11448224
[TBL] [Abstract][Full Text] [Related]
2. Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements.
Beaulieu PL; Cameron DR; Ferland JM; Gauthier J; Ghiro E; Gillard J; Gorys V; Poirier M; Rancourt J; Wernic D; Llinas-Brunet M; Betageri R; Cardozo M; Hickey ER; Ingraham R; Jakes S; Kabcenell A; Kirrane T; Lukas S; Patel U; Proudfoot J; Sharma R; Tong L; Moss N
J Med Chem; 1999 May; 42(10):1757-66. PubMed ID: 10346928
[TBL] [Abstract][Full Text] [Related]
3. Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56lck SH2 domain.
Llinaś-Brunet M; Beaulieu PL; Cameron DR; Ferland JM; Gauthier J; Ghiro E; Gillard J; Gorys V; Poirier M; Rancourt J; Wernic D; Betageri R; Cardozo M; Jakes S; Lukas S; Patel U; Proudfoot J; Moss N
J Med Chem; 1999 Feb; 42(4):722-9. PubMed ID: 10052978
[TBL] [Abstract][Full Text] [Related]
4. Lad, an adapter protein interacting with the SH2 domain of p56lck, is required for T cell activation.
Choi YB; Kim CK; Yun Y
J Immunol; 1999 Nov; 163(10):5242-9. PubMed ID: 10553045
[TBL] [Abstract][Full Text] [Related]
5. p56lck interacts via its src homology 2 domain with the ZAP-70 kinase.
Duplay P; Thome M; Hervé F; Acuto O
J Exp Med; 1994 Apr; 179(4):1163-72. PubMed ID: 8145035
[TBL] [Abstract][Full Text] [Related]
6. The Src homology 2 domain of the protein-tyrosine kinase p56lck mediates both intermolecular and intramolecular interactions.
Amrein KE; Panholzer B; Flint NA; Bannwarth W; Burn P
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10285-9. PubMed ID: 7694287
[TBL] [Abstract][Full Text] [Related]
7. The p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated T cell receptor/CD3/zeta complex.
Thome M; Germain V; DiSanto JP; Acuto O
Eur J Immunol; 1996 Sep; 26(9):2093-2100. PubMed ID: 8814252
[TBL] [Abstract][Full Text] [Related]
8. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A
Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927
[TBL] [Abstract][Full Text] [Related]
9. The Src homology-2 domains (SH2 domains) of the protein tyrosine kinase p56lck: structure, mechanism and drug design.
Broadbridge RJ; Sharma RP
Curr Drug Targets; 2000 Dec; 1(4):365-86. PubMed ID: 11467076
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS
Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421
[TBL] [Abstract][Full Text] [Related]
11. Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta complex.
Thome M; Duplay P; Guttinger M; Acuto O
J Exp Med; 1995 Jun; 181(6):1997-2006. PubMed ID: 7539035
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 domains.
Veillette A; Caron L; Fournel M; Pawson T
Oncogene; 1992 May; 7(5):971-80. PubMed ID: 1570157
[TBL] [Abstract][Full Text] [Related]
13. Binding, domain orientation, and dynamics of the Lck SH3-SH2 domain pair and comparison with other Src-family kinases.
Hofmann G; Schweimer K; Kiessling A; Hofinger E; Bauer F; Hoffmann S; Rösch P; Campbell ID; Werner JM; Sticht H
Biochemistry; 2005 Oct; 44(39):13043-50. PubMed ID: 16185072
[TBL] [Abstract][Full Text] [Related]
14. The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.
Dutartre H; Harris M; Olive D; Collette Y
Virology; 1998 Aug; 247(2):200-11. PubMed ID: 9705913
[TBL] [Abstract][Full Text] [Related]
15. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
Eck MJ; Shoelson SE; Harrison SC
Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases.
Livolsi A; Busuttil V; Imbert V; Abraham RT; Peyron JF
Eur J Biochem; 2001 Mar; 268(5):1508-15. PubMed ID: 11231305
[TBL] [Abstract][Full Text] [Related]
17. Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region.
Park I; Chung J; Walsh CT; Yun Y; Strominger JL; Shin J
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12338-42. PubMed ID: 8618896
[TBL] [Abstract][Full Text] [Related]
18. Rosmarinic acid inhibits TCR-induced T cell activation and proliferation in an Lck-dependent manner.
Won J; Hur YG; Hur EM; Park SH; Kang MA; Choi Y; Park C; Lee KH; Yun Y
Eur J Immunol; 2003 Apr; 33(4):870-9. PubMed ID: 12672052
[TBL] [Abstract][Full Text] [Related]
19. Identification of non-phosphate-containing small molecular weight inhibitors of the tyrosine kinase p56 Lck SH2 domain via in silico screening against the pY + 3 binding site.
Huang N; Nagarsekar A; Xia G; Hayashi J; MacKerell AD
J Med Chem; 2004 Jul; 47(14):3502-11. PubMed ID: 15214778
[TBL] [Abstract][Full Text] [Related]
20. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
Eck MJ; Atwell SK; Shoelson SE; Harrison SC
Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
